Cholesterol-lowering treatment of patients should

Question
Cholesterol-lowering treatment of patients should not be
Answer
First of all, patients with active hepatitis should not use cholesterol-lowering drugs. Because this type of lipid-lowering drugs in the liver metabolism, thus increasing the damage to the liver. Secondly, pregnant or lactating women should not use cholesterol-lowering drug. Because atherosclerosis is a chronic process, so out of lipid-lowering drugs during pregnancy, the treatment of primary hypercholesterolemia little effect on the long-term; Moreover, the cholesterol biosynthetic pathway and the other is a product of the fetal development necessary ingredients, including steroids and cell membrane synthesis. Lipid-lowering drugs statins to reduce cholesterol biosynthesis, but also a reduction of cholesterol biosynthesis pathway of itsIts product. Therefore, pregnant women taking these hypolipidemic drugs that may be detrimental to the fetus. Hypolipidemic drugs and their metabolites are secreted by human milk is still a lack of research. Because many drugs secreted by human milk and because of potential side effects of lipid-lowering drugs, so breast-feeding women should not be taking lipid-lowering drugs. Finally, it must be stressed that not all are suitable for patients with coronary heart disease to lower cholesterol treatment, over the age of 70 elderly patients with chronic congestive heart failure, dementia, cerebrovascular disease or late stage activity in patients with malignant tumors, are not taken lipid-lowering therapy. (Internship Editor: Mrs Sharon)